Cvs Health (CVS) Cash & Current Investments (2009 - 2026)

Cvs Health (CVS) has 18 years of Cash & Current Investments data on file, last reported at $11.8 billion in Q1 2026.

• Quarterly Cash & Current Investments fell 6.73% year-over-year to $11.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.8 billion (down 6.73% YoY) and the FY2025 annual result came in at $10.6 billion, down 3.59% from the prior year.
• Cash & Current Investments improved to $11.8 billion in Q1 2026, from $10.6 billion in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $20.0 billion in Q3 2022 to a low of $9.7 billion in Q3 2024.
• A 5-year average of $13.8 billion and a median of $13.1 billion in 2024 frame the typical range for Cash & Current Investments.
• Annual changes were most pronounced in 2023 — Cash & Current Investments surged 56.23% — and 2024, when it slumped 40.2%.
• Tracing CVS's Cash & Current Investments over 5 years: stood at $15.7 billion in 2022, then dropped by 27.14% to $11.5 billion in 2023, then declined by 4.03% to $11.0 billion in 2024, then slipped by 3.59% to $10.6 billion in 2025, then rose by 11.36% to $11.8 billion in 2026.
• The last three Cash & Current Investments figures came in at $11.8 billion (Q1 2026), $10.6 billion (Q4 2025), and $11.2 billion (Q3 2025), per Business Quant data.